693 studies found for:    Erythropoietin
Show Display Options
Rank Status Study
1 Completed Comparison Among Erythropoietin Stimulating Agents
Condition: Anemia of End Stage Renal Disease
Interventions: Drug: Epoetin alpha or beta (Epoetin group);   Drug: Darbepoetin alfa;   Drug: Methoxy polyethylene glycol-epoetin beta
2 Completed
Has Results
Allogenic Umbilical Cord Blood and Erythropoietin Combination Therapy for Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Biological: Umbilical Cord Blood Infusion;   Drug: Erythropoietin Injection;   Other: Active Rehabilitation;   Other: Placebo Umbilical Cord Blood;   Other: Placebo Erythropoietin
3 Completed Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
Conditions: Anemia;   Chronic Kidney Disease (CKD)
Interventions: Drug: HX575 epoetin alfa;   Drug: US-licensed epoetin alfa
4 Not yet recruiting Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery
Conditions: Heart; Dysfunction Postoperative, Cardiac Surgery;   Anemia, Iron-Deficiency
Intervention: Drug: Erythropoietin subcutaneously and Iron intravenously
5 Completed Blood Sparing Strategies: Single Shot High Dose Erythropoietin Two Days Before Heart Surgery
Condition: Blood Transfusion
Intervention: Drug: Erythropoietin
6 Terminated
Has Results
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy
Condition: Anemia - Cancer Related
Intervention: Drug: Erythropoietin: Observational study
7 Completed
Has Results
An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney Disease
Condition: Anemia
Interventions: Drug: Epoetin alfa 3 times weekly /once weekly;   Drug: Epoetin alfa once weekly;   Drug: Epoetin alfa once every two weeks
8 Unknown  Intraocular Pharmacokinetics of Erythropoietin After Single Intravitreal Injection in Human
Conditions: Pharmacokinetics;   Erythropoietin
Intervention: Procedure: Vitrectomy
9 Withdrawn Using Iron With Procrit in Advanced Lung Cancer Patients With Chemotherapy-Induced Anemia
Condition: Anemia
Intervention: Drug: Epoetin Alfa plus Iron
10 Withdrawn A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies
Condition: Anemia
Intervention: Drug: No intervention
11 Completed A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa
Condition: Pure Red-cell Aplasia
Intervention: Drug: No intervention
12 Completed The Effects of Erythropoietin (EPO) on the Transfusion Requirements of Very Low Birth Weight Infants
Conditions: Infant, Newborn;   Infant, Low Birth Weight;   Infant, Small for Gestational Age;   Infant, Premature;   Anemia, Neonatal
Interventions: Drug: Erythropoietin;   Other: Sham Comparator
13 Unknown  Relationship Between Erythropoietin Administration and Stress Responses in Trauma Patients
Condition: Multiple Trauma
Interventions: Drug: erythropoietin;   Drug: placebo
14 Enrolling by invitation Efficacy of Erythropoietin to Prevent Acute Kidney Injury in Chronic Kidney Disease Patients Undergoing Cardiac Surgery
Condition: Acute Renal Failure
Interventions: Drug: beta erythropoietin;   Drug: placebo
15 Completed Renal Effects of Erythropoietin in Humans
Condition: Renal Effects
Interventions: Drug: Erythropoietin (Epoetin-beta, NeoRecormon®);   Drug: Placebo
16 Not yet recruiting Erythropoietin Therapy for Children With Cerebral Palsy
Condition: Cerebral Palsy
Interventions: Drug: Erythropoietin;   Drug: Placebo erythropoietin
17 Active, not recruiting Efficacy Study of Epoetin Alfa in Friedreich Ataxia
Condition: Friedreich Ataxia
Interventions: Drug: Epoetin alfa;   Drug: Placebo
18 Terminated
Has Results
Treating Patients With Aneurysmal SubArachnoid Hemorrhage (SAH) With Epoetin Alfa
Condition: Subarachnoid Hemorrhage
Interventions: Drug: Epoetin alfa;   Drug: Saline
19 Active, not recruiting Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
Conditions: Hypoxic-ischemic Encephalopathy;   Neonatal Encephalopathy;   Birth Asphyxia
Interventions: Drug: Erythropoietin;   Drug: Normal saline
20 Completed
Has Results
Effects of Erythropoietin on Cerebral Vascular Dysfunction and Anemia in Traumatic Brain Injury
Conditions: Anemia;   Traumatic Brain Injury
Interventions: Drug: recombinant human erythropoietin, rhEpo;   Other: placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years